During petroleum refining, a large number of products are generated which have varying chemical and physical properties. These are known In the industry as petroleum streams. In order to characterize their carcinogenic activity, a number of these commercially produced streams were administered to C3H/HeJ mice in chronic dermal bioassays. The bioassays were conducted using one of two study designs: the first set of test materials was applied for a lifetime and the second set for 24 months. In the Lifetime study, the last mice in the test groups survived for periods of 31 to 32 months. Middle distillates, boiling in the range 115-390°C, were found to decrease the lifespan of exposed mice compared to controls or streams of higher and lower boiling ranges. These middle distillate streams included straight run kerosine, hydrodesulfurized middle distillate, straight run middle distillate, light catalytic cracked distillate, and 90/10% and 70/30% mixtures of the last two. The middle distillate streams also proved to be active as carcinogens, with tumor incidence ranging from 16 to 67%. Light alkylate naphtha, heavy catalytic reformed naphtha, vacuum residuum, and unleaded gasoline did not demonstrate significant carcinogenic potency. Heavy thermal cracked naphtha, heavy catalytic cracked naphtha, and hydrotreated light naphthenic distillate were dermal carcinogens of low potency in this study. Administration of light catalytic cracked naphtha led to a low incidence of very late developing tumors with a mean latency of 118 weeks. Application of the 0.1% solution of catalytic cracked clarified oil in toluene did not result in a significant incidence of tumors, but the 10% solution caused almost 100% mortality and 100% tumor incidence in 12 months. There was no correlation between carcinogenic potency and the indices of irritation, alopecia, erythema, and scabbing.
During petroleum refining, a large number of products are generated which have varying chemical and physical properties. These are known In the industry as petroleum streams. In order to characterize their carcinogenic activity, a number of these commercially produced streams were administered to C3H/HeJ mice in chronic dermal bioassays. The bioassays were conducted using one of two study designs: the first set of test materials was applied for a lifetime and the second set for 24 months. In the Lifetime study, the last mice in the test groups survived for periods of 31 to 32 months. Middle distillates, boiling in the range 115-390°C, were found to decrease the lifespan of exposed mice compared to controls or streams of higher and lower boiling ranges. These middle distillate streams included straight run kerosine, hydrodesulfurized middle distillate, straight run middle distillate, light catalytic cracked distillate, and 90/10% and 70/30% mixtures of the last two. The middle distillate streams also proved to be active as carcinogens, with tumor incidence ranging from 16 to 67%. Light alkylate naphtha, heavy catalytic reformed naphtha, vacuum residuum, and unleaded gasoline did not demonstrate significant carcinogenic potency. Heavy thermal cracked naphtha, heavy catalytic cracked naphtha, and hydrotreated light naphthenic distillate were dermal carcinogens of low potency in this study. Administration of light catalytic cracked naphtha led to a low incidence of very late developing tumors with a mean latency of 118 weeks. Application of the 0.1% solution of catalytic cracked clarified oil in toluene did not result in a significant incidence of tumors, but the 10% solution caused almost 100% mortality and 100% tumor incidence in 12 months. There was no correlation between carcinogenic potency and the indices of irritation, alopecia, erythema, and scabbing. Only two of the streams tested, hydrotreated light naphthenic distillate and 10% catalytic cracked clarified oil, contain polynuclear aromatic hydrocarbons (PNAs) and may be presumed to be complete carcinogens. The middle distillates and heavy naphthas are nonmutagenic and essentially free of PNAs. Their activity may result from promotion of already-initiated skin sites. Where comparisons could be made, reducing the exposure period from a lifetime (29-32 months) to 24 months did not change the evaluations of stream carcinogenicity except in the case of light catalytic cracked naphtha where six of the seven mice that developed tumors did so after 24 months, o 1996 soday of Toxico^e For a number of years the American Petroleum Institute (API) has sponsored research into the carcinogenic activity of the various streams produced in the refining of crude oil. The refining processes include, among others, distillation to yield fractions of differing boiling ranges, alkylation to produce branched-chain saturated hydrocarbons from lowmolecular-weight unsaturated compounds, reforming to provide aromatic hydrocarbons, catalytic cracking to create more volatile streams from less volatiles ones, hydrotreatment to obtain saturated hydrocarbons from unsaturated streams, and solvent refining to remove polynuclear aromatic hydrocarbons (PNAs) from lubricating base oil streams. The involvement of the API was preceded by reports of human cancer, especially scrotal cancer, associated with exposure to "mineral oils" (Bell, 1876; Cruickshank and Squire, 1950; Henry, 1946 Henry, , 1947 Lione and Denholm, 1959; VoLkmann, 1875; Waterhouse, 1971) . Although the most potent of these mineral oils were derived from coal tar (Kennaway, 1934) and shale oil (Leitch, 1922) , animal tests (Twort and Twort, 1931) confirmed that some petroleum oils were also active. Twort and Twort (1939) identified some of the active compounds in petroleum-derived mineral oils as PNAs of characteristic molecular weight and structure. Bingham and Horton (1966) demonstrated that processing history is a critical determinant of carcinogenic activity in mineral oils and that those processing steps which might be expected to reduce or eliminate PNAs also reduced or eliminated carcinogenic activity. Roy et al. (1988) reported that mutagenicity and carcinogenicity of petroleum-derived mineral oils with median boiling points of 260-577°C were highly correlated with concentration of 3-to 7-ring PNAs. Craig (1989) reviewed the good correlations between carcinogenicity of lubricating base oils and PNA content and mutagenicity as determined using a modified Ames test. He also noted that middle distillates and heavier naphthas possessed low to moderate carcinogenic potency even though free of PNAs and nonmutagenic.
Beginning in 1975, the API contracted to have two wellcharacterized crude oils refined by distillation into fractions with the following boiling ranges: <49, 49-177, 177-288, 288-371, 371-577 , and >577°C. These corresponded . roughly to streams produced in commercial refinery distilla-tion operations. The streams were tested for dermal tumorigenic potency and the results were reported by Lewis (1983) . The 371-577°C fraction was the most active, as was expected, since it contained nearly all of the PNAs with carcinogenic potency. The next lower boiling fraction, 288-371°C, and the residue boiling over577°C were essentially noncarcinogenic as was the fraction boiling under 49°C. However, the 49-177 and 177-288°C fractions were found to have moderate tumorigenic potency even though their concentrations of PNAs were negligible. Haider et al. (1984) and Kane et al. (1984) examined the carcinogenic activity of refinery streams used to manufacture lubricating oils. They demonstrated that solvent refining sufficient to remove carcinogenic PNAs eliminated the carcinogenic potency of these base stocks. Doak et al. (1985) reported that severe hydrotreatment also eliminated the carcinogenicity of lubricating base stocks. Witschi et al. (1987) and Biles et al. (1988) exposed mice chronically to petroleum middle distillates with boiling ranges between 140 and 370°C and found them to be carcinogenic but of relatively weak potency. Initiation/promotion experiments were carried out on middle distillates by Gerhart et al. (1988) , McKee et al. (1989) , Skisak (1991) , and Skisak et al. (1994) . All these authors reported that the middle distillates acted as promoters rather than initiators of carcinogenesis.
In order to characterize the carcinogenic activity of petroleum refinery streams more fully and to include processing treatments in addition to distillation, the API sponsored an extensive series of dermal bioassays of streams representing a wide spectrum of distillation ranges and physical and chemical treatments, generating the data presented here and in Skisak et al. (1994) .
MATERIALS AND METHODS
Materials. The test articles were obtained from the API repository (Experimental Pathology Laboratories, Herndon, VA). An API task force of industry toxicologists selected the test materials which were representative of streams produced during petroleum refining. The streams have been characterized for inclusion in the EPA listing of materiaJs covered by Toxic Substances Control Act regulations and given Chemical Abstract Service (CAS) identification numbers. Table 1 is a listing of the streams, their CAS numbers, and their boiling ranges. The streams characterized as light naphthas are the most volatile ones tested followed by the heavy naphthas and the middle distillates: straight run kerosine, hydrodesulfurized middle distillate, straight run middle distillate, and light catalytic cracked distillate. The 90/10 (%) and 70/30 mixtures of straight run middle distillate and light catalytic cracked distillate were included in the study because they are representative of commercial No. 2 fuel oil formulations. Unleaded gasoline is a mixture of various naphthas as can be inferred from its boiling range. Hydrotreated light naphthenic distillate is a low viscosity lubricating oil base stock. Catalytic cracked clarified oil is the residual fraction of distillation of the products from a catalytic cracking process. The least volatile stream, vacuum residuum, is the residue of vacuum distillation of the material remaining after atmospheric distillation of crude oil.
The test articles were stored at 4°C and in 25-ml glass bottles under nitrogen. At approximately 2-week intervals, fresh bottles were removed from the refrigerator and held at room temperature for dermal application Twenty-four-month application period. * Lifetime application period. c These products have no CAS numbers because they are mixtures of streams.
Toluene, ACS grade, and benzo-a-pyrene (BaP) were obtained from the Aldrich Chemical Co. (Milwaukee, WI).
Dosage/Formulations.
Vacuum residuum was applied as a 50% (w/v) solution in toluene. Two dilutions of catalytic cracked clarified oil, 10 and 0.1 % (w/v) in toluene were formulated for application. All other test articles were applied neat. BaP was applied as 0.01 and 0.05% (w/v) solutions in toluene.
Animals, housing, and diet. C3H/HeJ male mice were acquired from Jackson Laboratories (Bar Harbor, ME). Mice were 7-9 weeks of age at study initiation. Mice were randomized upon receipt, double-housed in suspended stainless steel cages for a quarantine period, and then singly housed prior to study initiation. Each mouse was uniquely identified by toeclips. Some groups were quarantined for 2 weeks and held for I week, others were quarantined for 1 week and held for 2. Punna Certified Rodent Chow 5002 was provided ad libitum. Deionized tap water was provided ad libitum by bottle Animal rooms were maintained at 24.5 ± I.7°C (SD) and relative humidity at 40 ± 10% (SD). A 12-hr light/dark cycle was maintained Experimental design. The mice were randomly divided into groups of 50 mice each. In addition to the test groups, one group received no treatment, and two groups were administered BaP (0.01 and 0.05%) as positive controls Since two samples were diluted with toluene, a separate toluene group was included as a vehicle control. The studies were carried out in two segments with application in the initial one extending over the lifetime of each animal. Although some mice in this segment survived for 32 months, the small amount of information available after 24 months did not seem to justify the considerable costs of a study of this duration. Therefore, in die next segment, application was limited to 24 months. The test articles and the positive and solvent controls, BaP and toluene, were applied as 50-^1 doses twice weekly. Positive, solvent, and sham-handled controls were included for each treatment segment. All mice not dying on study were killed by ethyl ether inhalation and exsanguinated by puncturing the posterior vena cava. In-life and postmortem examinations. Physical examinations for dermal irritation and tumors were performed weekly. Dermal irritation was evaluated by measuring incidence and estimating severity of erythema, alopecia, and scabbing. A dermal lesion was diagnosed as a tumor when the mass reached 1 mm in diameter. All mice were subjected to a limited necropsy upon death or euthanasia. Application site skin was removed and fixed in 10% neutral-buffered formalin. Skin sections were embedded in paraffin, sectioned, stained with hematoxylin and eosin, and examined microscopically.
Statistical methods. Only those tumors confirmed by histological examination were used in calculating incidence. Significance of differences between test and control tumor incidences was analyzed by x 2 (Snedecor and Cochran, 1980) . The Fisher's Exact Test (one-tailed) was used when comparing low-tumor incidence groups to the appropriate control. Final effective number (FEN) is the denominator used in calculating tumor incidence. When median time to tumor was under 60 weeks, the number of animals alive at that time was used as the FEN. When median time to tumor was over 60 weeks, the number of animals alive at 60 weeks plus any mice dying with tumors before 60 weeks was used as the FEN. Latency was measured as the time in weeks from initiation of dosing to appearance of the first tumor.
RESULTS
Groups of mice exposed to all test materials except vacuum residuum exhibited some degree of dermal irritation. Listed in Table 2 are visual estimates of levels of irritative responses, alopecia, erythema, and scabbing, noted at the exposure time when they stabilized, usually about a year. Very mild irritative signs were seen in animals exposed to light alkylate naphtha, light catalytic cracked naphtha, heavy catalytic reformed naphtha, hydrotreated light naphthenic distillate, 0.1 % catalytic cracked clarified oil, and unleaded gasoline. Irritation classified as mild occurred in groups exposed to heavy catalytic cracked naphtha, straight run kerosine, 10% catalytic cracked clarified oil, and straight run middle distillate. Exposure to the rest of the streams, heavy thermal cracked naphtha, light catalytic cracked distillate, hydrodesulfurized middle distillate, and the 90/10 and 70/ 30 mixtures, resulted in moderate irritation. Table 3 presents the survival data measured at 6-month intervals. One inference from the table is that survival appears to have been higher in the lifetime-exposed groups than in those exposed for 24 months. When survival in comparable groups at 24 months is examined, it is evident that more mice were alive in the sham-treated, toluene, and BaP groups exposed for a lifetime than in those exposed for 24 months. This higher survival rate requires consideration when making toxicological judgments and comparisons among the groups. With this proviso, examination of the information in Table 3 indicates that vacuum residuum, unleaded gasoline, and the naphtha streams are relatively nontoxic when mortality is used as the index. The group exposed to catalytic cracked clarified oil 0.1% also has a low mortality at 24 months, but this is a result of its low concentration rather than an inherent property of the stream since exposure to 10% catalytic cracked clarified oil led to 94% mortality at 12 months with no survivors at 18 months. The middle distillate streams all showed elevated mortality at 18 months. With the possible exception of straight run middle distillate, few mice or none survived 24 months of exposure to these streams. Table 4 shows the numbers of mice with histopathologically characterized tumors and the mean latencies of tumor appearance. Sham-treated controls were free of any skin tumors in both 24-month and lifetime studies. The streams that did not develop significant numbers of tumors compared to their respective controls were light alkylate naphtha, heavy catalytic reformed naphtha, 0.1% catalytic cracked clarified oil, vacuum residuum, and unleaded gasoline. The remaining naphthas, light catalytic cracked naphtha, heavy thermal cracked naphtha, and heavy catalytic cracked naphtha, demonstrated relatively low numbers of tumors which were, however, significant when compared to the zero incidence in sham-treated controls. Application of all the middle distillates led to significant tumor development in mice ranging from 16% incidence in the group exposed to the 90/10 mixture to 67% in the group exposed to straight run kerosine.
For a few samples, the differences in tumor incidence between exposure for 24 months and for a lifetime could be compared. These were groups exposed for a lifetime in which significant numbers of animals survived for 30 months and the toluene and BaP controls which were run in both segments. These comparisons are made in Table 5 which shows general agreement between tumor incidences at 24 months and at lifetime termination. A possible exception occurred during exposure to light catalytic cracked naphtha where six mice developed tumors between 24 months and termination at 32 months. This comparison may not be exact, however, because the 24-month incidence is based on visual observation while the lifetime number is histologically determined. Although four mice developed tumors in the lifetime toluene segment compared with one in the 24-month segment, the significance of this difference is lessened by the fact that only two mice developed tumors after lifetime exposure to 0.1% catalytic cracked clarified oil, which is 99.9% toluene.
Although an occasional malignant melanoma or malignant lymphoma (a total of four each in all the groups combined) appeared at the application site, they did not affect the statistical significance of total tumor incidence. The most common tumors were fibromas, fibrosarcomas, squamous cell papillomas, and squamous cell carcinomas. The numbers of animals in each group developing these tumors are listed in Table  6 . It is obvious from the table that the great majority of them are malignant squamous cell carcinomas and fibrosarcomas rather than benign papillomas and fibromas. Although the squamous cell papillomas and carcinomas are of epithelial origin and the fibromas and fibrosarcomas are mesothelial tumors, there seems to be a rough correlation between them, i.e., groups with large numbers of squamous cell carcinomas usually also have large numbers of fibrosarcomas.
DISCUSSION
One generalization which can be drawn from the data is that the middle distillates appear to be more toxic on chronic dermal administration than the other streams tested except for 10% catalytic cracked clarified oil. Using the 24-month survival data in Table 3 for comparison, it can be seen that only one of the six middle distillate streams tested, straight run middle distillate, had higher than 8% survival. Three middle distillate streams, the two mixtures and hydrodesulfurized middle distillate, did not have any surviving animals. The reasons for this higher toxicity are unknown, but may be related to the molecular size ranges of the components of the streams. The low-molecular-weight naphthas are quite volatile and may not reside on the skin long enough for systemic absorption of toxic quantities while higher molecular-weight streams may be too large to be efficiently absorbed. The low toxicity of 0.1 % catalytic cracked clarified oil is due to its extreme dilution since application of a 10% solution of this material led to only 6% survival at 12 months and 100% mortality before 18 months. Skisak et al. (1994) reported that chronic dermal application of 1% catalytic cracked clarified oil led to significantly higher mortality in treated mice over controls at 24 months. Biles et al. (1988) conducted a series of lifetime dermal carcinogenesis studies on middle distillates. They did not observe reduced survivability in the test groups compared to mineral oil controls. Their administration schedule was different from that in the present study, however, consisting of three applications per week of 25 /xl. Therefore their total weekly application volume was 75 /xl and ours was 100 /xl, and this difference may account for the higher toxicity observed in our study. Alternatively, there may be a threshold daily dose necessary to achieve toxicity which was exceeded by the 50 /xl used in this study but not by the 25 /xl applied by Biles et al.
The incidence rates of application site tumors identified at termination and mean latencies for their appearance are given in Table 4 . The streams exhibiting statistically insignificant numbers of tumors included light alkylate naphtha, heavy catalytic reformed naphtha, 0.1% catalytic cracked clarified oil, vacuum residuum, and unleaded gasoline. The mice exposed to light catalytic cracked naphtha developed tumors very late, with six of the seven tumors appearing after 24 months. Heavy thermal cracked naphtha and heavy catalytic cracked naphtha demonstrated low tumor incidence. These results show some agreement with those of Lewis (1983) who reported tumorigenic activity in experimental distillate fractions of crude oil with boiling ranges of 49-177 and 177-288°C. There were important differences between the streams examined by Lewis (1983) and those in this study. The fractions examined by Lewis were untreated except for distillation, whereas those reported here represent complex physical and chemical treatments as well as distillation. The absence of tumors in mice exposed to heavy catalytic reformed naphtha is evidence of the probably noncarcinogenic character of the alkyl-substituted benzenes which make up this stream.
Hydrotreated light naphthenic distillate is a low viscosity oil which has been hydrogenated. Hydrotreatment is intended to reduce or eliminate unsaturation and aromaticity of PNAs and to cleave heterocyclic compounds with consequent reduction or elimination of carcinogenicity (Haider et al., 1984) . The International Agency for Research on Cancer (1984) has determined that sufficient evidence exists that mildly hydrogenated oils are carcinogenic to animals, but that evidence is inadequate to evaluate severely hydrotreated oils. The degree of hydrotreatment of the stream used in this study was undetermined, but the 15% incidence of tumors obtained indicates that the tumorigenic potency of the stream is low.
The 10% solution of catalytic cracked clarified oil in tolu- " Lifetime study: histopathologicaJly identified tumors at termination are compared to visually identified tumors at 24 months in the same study.
* Histopathologically identified tumors in the 24-month study are compared to such tumors in the lifetime study.
our middle distillate streams revealed similarly low concentrations of PNAs.
Recent papers (Gerhart et al., 1988; Skisak, 1991; Skisak et al., 1994) have reported on the results of initiation/ promotion studies on middle distillates. In these investigations, middle distillates resulting from various treatments have been consistently shown to be tumor promoters and not tumor initiators. Skisak et al. (1994) hypothesized that middle distillates might act as carcinogens by selectively inducing cellular proliferation at skin sites previously initiated by background mutagens. The role of irritation in promotion of carcinogenesis has been debated (Frei and Stephens, 1968; Gerhart et al., 1988; Scribner and Suss, 1978; Skisak, 1991) . The irritation hypothesis usually identifies compensatory reparative hyperplasia following irritation and injury as the event critical to promotion. Skisak (1991) was able to neutralize the dermal carcinogenic activity of a middle distillate by concurrent treatene proved to be a stronger carcinogen than 0.05% BaP. Although exposure to each resulted in 100% incidence of skin tumors, mean latency was only 22 weeks in the catalytic cracked clarified oil groups compared to 49 weeks in those exposed to 0.05% BaP. Catalytic cracked clarified oils may contain 5% or more of 4-and 5-member condensed ring aromatic hydrocarbons, and possibly aromatic heterocyclic compounds as well, and this may explain the potency of this poorly characterized stream. Biles et al. (1988) utilized dilutions of catalytic cracked clarified oil as positive controls in their examination of middle distillate carcinogenicity. Skisak et al. (1994) reported that chronic application of a 1% solution of catalytic cracked clarified oil to mice led to 100% tumor incidence but with a mean latency of 72 weeks. Further dilution to 0.1% appears to essentially eliminate the activity of the stream.
The rest of the materials tested were middle distillate streams or binary mixtures of middle distillate streams. They were all tumorigenic, although potency was quite variable with a tumor incidence of 16% after treatment for the 90/ 10 mixture to 67% for straight run kerosine. The potency of the mixture is somewhat in doubt since it is lower than that of either of its two components. There is no obvious correlation of potency with boiling range since the most volatile middle distillate stream, straight run kerosine, is among the most potent while the highest boiling stream, straight run middle distillate, is of relatively low potency. The positive findings for the middle distillates are in agreement with previous investigations on such materials (Biles etal., 1988; Lewis, 1983; Witschi et ai, 1987) , which have consistently found middle distillates to be carcinogenic in chronic dermal experiments. Biles etal. (1988) discounted PNAs as a cause of the activity because their concentration was too low to have contributed to the activity. Analysis of ment with dexamethasone which inhibits cellular replication. However, dexamethasone has a number of other physiological effects which may determine or influence the anti-promoting activity. Thus far, no study has correlated degree of irritation with carcinogenic potency, and the results in Table 2 also show a lack of correlation. Biles et al. (1988) found that groups demonstrating the greatest degree of epidermal degeneration and necrosis produced the lowest tumor yields. However, it may be that such severe responses inhibit reparative hyperplasia rather than increase it. With some exceptions as indicated in Table 2 , the naphtha streams were generally less irritating than the middle distillates and were also less potent as carcinogens. Within each of the groups of streams classified as naphthas and as middle distillates, however, there did not appear to be a correlation between carcinogenic and irritative activity. Vacuum residuum, a mixture of very high molecular weight compounds with very low volatility which did not possess significant carcinogenic activity, was the only stream tested which resulted in no signs of irritation in treated mice.
Although the naphtha streams are defined as being more volatile than the middle distillates, there is actually a continuum of boiling ranges among the various streams, and there is considerable overlap between the upper ranges of the heavy naphthas and the lower ranges of the middle distillates. It is not unexpected, therefore, that the heavy naphthas should have the low carcinogenic activity shown in this study. In fact, the 49-177°C distillate fraction of the crude oils in the Lewis (1983) study, which was in the boiling range of naphtha streams, was tumorigenic.
Most refinery streams, including naphthas, are mixtures of various organic compound classes. Because of this, it is difficult to associate carcinogenic activity of the streams with any particular type of compound. However, some of the naphthas are products of treatments which lead to one compound type predominantly. More than 90% of our sample of heavy catalytic reformed naphtha consisted of alkyl-substituted benzenes, and light alkylate naphtha is made up almost completely of branched-chain aliphatic hydrocarbons. The lack of activity of these streams suggests that these classes of compounds are not dermal carcinogens, at least in the molecular weight ranges found in the naphthas. Horton et al. (1957) and Sice (1966) showed that aliphatic straight-chain hydrocarbons of particular size, such as dodecane, were accelerators or promoters of carcinogenesis. Varying concentrations of these or similar compounds may be expected to occur in naphthas, particularly heavy naphthas, and middle distillates. These may determine or contribute to the activity of these streams.
